Neurosurgery, Department of Neurological Sciences, Policlinico Umberto I, University of Rome “Sapienza”, Viale del Policlinico, Rome, Italy
Neurosurgery, Department of Neurological Sciences, Policlinico Umberto I, University of Rome “Sapienza”, Viale del Policlinico, Rome, Italy
Neurosurgery, Department of Neurological Sciences, Policlinico Umberto I, University of Rome “Sapienza”, Viale del Policlinico, Rome, Italy
Neurosurgery, Department of Neurological Sciences, Policlinico Umberto I, University of Rome “Sapienza”, Viale del Policlinico, Rome, Italy
Neurosurgery, Department of Neurological Sciences, Policlinico Umberto I, University of Rome “Sapienza”, Viale del Policlinico, Rome, Italy
Neurosurgery, Department of Neurological Sciences, Policlinico Umberto I, University of Rome “Sapienza”, Viale del Policlinico, Rome, Italy
Neurosurgery, Department of Neurological Sciences, Policlinico Umberto I, University of Rome “Sapienza”, Viale del Policlinico, Rome, Italy
Copyright © 2014 Alessandro D’Elia, Vincenza Maiola, Mirena Manucci, Angelo Pichierri, Alessandro Frati, Felice Giangaspero, Maurizio Salvati et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
A. D’Elia, V. Maiola, M. Manucci, A. Pichierri, A. Frati, F. Giangaspero and M. Salvati, "Extended Daily Schedule of Temozolomide in Recurrent Glioblastoma: Single-Institution Report on a Series of 43 Patients,"
Journal of Cancer Therapy, Vol. 5 No. 2, 2014, pp. 155-166. doi:
10.4236/jct.2014.52019.